AMNEAL PHARMACEUTICALS, INC., S-3ASR filed on 9/3/2026
Automatic shelf registration statement of securities of well-known seasoned issuers
v3.26.1
Submission
Sep. 03, 2026
Submission [Line Items]  
Central Index Key 0001723128
Registrant Name AMNEAL PHARMACEUTICALS, INC.
Form Type S-3
Submission Type S-3ASR
Fee Exhibit Type EX-FILING FEES
v3.26.1
Offerings - Offering: 1
Sep. 03, 2026
USD ($)
shares
$ / shares
Offering:  
Fee Previously Paid false
Other Rule true
Security Type Equity
Security Class Title Class A Common Stock, par value $0.01 per share
Amount Registered | shares 28,942,098
Proposed Maximum Offering Price per Unit | $ / shares 17.39
Maximum Aggregate Offering Price $ 503,303,084.22
Fee Rate 0.01381%
Amount of Registration Fee $ 69,506.15
Offering Note
  
(1)
Pursuant to Rule 416 under the Securities Act, the shares of Class A common stock being registered hereunder include such indeterminate number of shares of Class A common stock as may be issuable with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.
(2)
Pursuant to Rule 457(c) under the Securities Act, and solely for the purpose of calculating the registration fee, the proposed maximum offering price per share is $17.39, which is the average of the high and low prices of the Class A common stock on August 31, 2026 on the Nasdaq Stock Market LLC.
v3.26.1
Fees Summary
Sep. 03, 2026
USD ($)
Fees Summary [Line Items]  
Total Offering $ 503,303,084.22
Previously Paid Amount 0
Total Fee Amount 69,506.15
Total Offset Amount 0
Net Fee $ 69,506.15
Offset Table N/A N/A
Combined Prospectus Table N/A N/A